Scholarly Activity

Dr. Heavner has published and presented in her areas of expertise. Please see some of the selected publications and presentations below:

Publications

  1. Mullins CD, Palumbo FB, Saba M. Formulary tier placement for commonly prescribed branded drugs: benchmarking and creation of a preferred placement index. Am J Manag Care. 2007 Jun;13(6 part 2):377-384.
  2. Paul SC, Saba M, Berger K. Revisiting an old therapy: theophylline in asthma. JAEE. 2010 Oct;1(5):180-183.
  3. Cirulli J, McMillian W, Saba M, Stenehjem D. Adaptive trial design: the future of clinical research and the impact on pharmacists. Am J Health Syst Pharm. 2011 May; 68(9):807-813.
  4. Heavner J, Saba M, Adverse drug interactions. In Yale Office-based Medicine Curriculum, eds. J. Rosenbaum, S. Hay, L. Whitman, M. Warner, 7th edition. New Haven, CT: Yale University.
  5. Ruggero MA, Argento AC, Heavner MS, Topal JE. Molecular Adsorbent Recirculating System (MARS®) removal of piperacillin/tazobactam in a patient with acetaminophen-induced acute liver failure. Transpl Infect Dis. 2013 Apr; 15(2):214-218.
  6. Heavner MS, Tichy EM, Yazdi M, Formica RN, Kulkarni S, Emre S. Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients. Am J Health Syst Pharm. 2013 Sept; 70(17):1507-1512.
  7. Farrokh S, Castle AC, Heavner MS, Pisani MA. Continuation rate of atypical antipsychotics after discharge when initiatied in the intensive care unit. J Pharm Pract. 2016 Apr 28; 2016.
  8. Heavner MS, Tichy EM, Yazdi M. Stepping it up: Implementation of a Pharmacist Career Ladder Program. Am J Health Syst Pharm. 2016;73:1524-30.
  9. Heavner MS, Rouse GE, Lemieux SL, Owusu KA, Pritchard D, Yazdi, M, Lee L. Experience with integrating pharmacist documenters on cardiac arrest teams to improve quality. JAPhA. 2017 [epub ahead of print].
  10. Heavner MS, Zhang M, Bast CE, Parker L, Eyler RF. Thrombolysis for massive pulmonary embolism in pregnancy. Pharmacotherapy. 2017 [accepted manuscript].

Poster Presentations

  1. Saba M, Tsukerman M, Miller L, Stump L. Development of medical service representative guidelines at an academic medical center.  American Society of Health-System Pharmacists Midyear Clinical Meeting, and University Health-System Consortium Annual Meeting, December 2008. Orlando, FL.
  2. Saba M, Tichy E. Evaluation of sodium citrate as a hemodialysis catheter-locking agent. Eastern States Residency Conference Annual Meeting, May 2009. Hershey, PA.
  3. Saba M, Tichy E, Formica RN, Kulkarni S. Tacrolimus: Generic vs. brand comparison. Eastern States Residency Conference, May 2010. Hershey, PA.
  4. Jessmer J, Saba M, Yazdi M, Siner J, Topal J. Use of the clinical pulmonary infection score to guide duration of antibiotic therapy in medical intensive care unit patients with healthcare associated pneumonia. American Society of Health-System Pharmacists Midyear Clinical Meeting, and University Health-System Consortium, December 2010. Anaheim, CA.
  5. Saba M, Tichy EM, Yazdi M, Formica RN, Kulkarni S. Clinical impact of an inpatient tacrolimus substitution program. Poster, American Transplant Congress, April 2011. Philadelphia, PA.
  6. Jessmer J, Saba M, Chan C, Yazdi M, Pauli M, Siner J, Topal J. Use of the clinical pulmonary infection score to guide duration of antibiotic therapy in medical intensive care unit patients with healthcare associated pneumonia. American College of Clinical Pharmacy Annual Meeting, Pittsburgh, PA. September 2011.
  7. Kurczewski L, Jessmer J, Saba M, Chan C, Siner J, Topal J. Implementation of a pharmacist-driven antibiotic discontinuation program using the clinical pulmonary infection score for healthcare associated pneumonia. American Society of Health-System Pharmacists Midyear Clinical Meeting, and University Health-System Consortium Annual Meeting, December 2011. New Orleans, LA.
  8. Heavner JJ, Erb C, Heavner MS. Cardiac arrest following pleurodesis: lipid rescue for lidocaine overdose. American College of Chest Physicians Annual Meeting, Critical Care Cases Presentation Session. October 2012. Atlanta, GA.
  9. Heavner JJ, Akgun, KM, Heavner MS, Chan CY, Drew M, Jackson PD, Pritchard D, Honiden S. The Yale Alcohol Withdrawal Protocol: the impact of a symptom-triggered protocol on clinical outcomes in intensive care unit patients with alcohol withdrawal syndrome. American Thoracic Society International Conference, May 2014. San Diego, CA.
  10. Farrokh S, Castle A, and Heavner MS. Characterization of atypical antipsychotic prescribing practices in the treatment of intensive care unit delirium. American Delirium Society Annual Meeting, June 2014. Baltimore, MD.
  11. Heavner K, Sarigianis J, Heavner MS, Cabie M, Abdelghany O. Effect of pharmacist education on medication adherence across transitions of care in chronic obstructive pulmonary disease patients. American Society of Health-System Pharmacists Midyear Clinical Meeting, and University Health-System Consortium, December 2014. Anaheim, CA.
  12. Hebert D, Morris G, Heavner MS, Lodice D, Castle A. Pharmacist handoff bundle. American Society of Health-System Pharmacists Midyear Clinical Meeting, and University Health-System Consortium. December 2014. Anaheim, CA.
  13. Littlefield A, Adams K, Lupi K, Stutsky M, Heavner MS. Fixed-schedule vs. symptom-triggered benzodiazepine administration in alcohol withdrawal syndrome using CIWA. American Society of Health-System Pharmacists Midyear Clinical Meeting, and University Health-System Consortium, December 2014. Anaheim, CA.
  14. Heavner JJ, Akgun, KM, Heavner MS, Chan CY, Honiden S. The Yale Alcohol Withdrawal Protocol: Cost analysis of a symptom-triggered protocol implemented in the intensive care unit. American Thoracic Society International Conference, May 2015. Denver, CO.
  15. Littlefield, A, Lupi K, Stutsky M, Adams K, Heavner MS. Fixed-schedule vs. symptom-triggered benzodiazepine administration in alcohol withdrawal syndrome using CIWA. American College of Clinical Pharmacy Annual Meeting, October 2015. San Francisco, CA.
  16. Adams K, Dowers E, Stutsky M, Ko E, Heavner, MS. Implementation of an inpatient pharmacist-managed warfarin dosing pilot. American Society of Health-System Pharmacists Midyear Clinical Meeting, and University Health-System Consortium, December 2015. New Orleans, LA.
  17. Cardinale M, Heavner MS, Chan C, Heavner JJ. Association between compliance to the Yale Alcohol Withdrawal Protocol and outcomes. Society of Critical Care Medicine Annual Meeting, February 2016. Orlando, FL.
  18. Lemieux SM, Heavner JJ, Morris GE, Siner J, DeVaux L, Topal J, Anderson A, Heavner MS. Improving time to antibiotics for medical intensive care unit patients with septic shock: risk factor prediction. American Thoracic Society International Conference, May 2016. San Francisco, CA.

Platform Presentations

  1. Farrokh S, Castle A, Heavner MS. Meet the SIM-MAN. Catch the Wave, Connecticut Society of Health-System Pharmacists Annual Meeting, November 2012. Cromwell, CT.
  2. Heavner MS. Special considerations in geriatrics: pain, agitation, and delirium in the ICU. American College of Clinical Pharmacy Annual Meeting. October 2013. Albuquerque, NM.
  3. Heavner MS Nuzzo J, Heavner JJ, Veiga F, Pritchard D, Fekieta R, Morris GE, Semlow M, Jenq G, Devlin M, Testa K, Crede W. Outcomes after advanced cardiovascular life support: implementation of pharmacist documentation during cardiac arrest events. American College of Clinical Pharmacy Annual Meeting, The Great Eight Best Paper Presentations. October 2014. Austin, TX.
  4. Heavner MS, Havriliak R. Pharmacy dashboards: beyond the numbers. Connecticut Pharmacist Association Mid-Winter Meeting. February 2016. Southington, CT.
  5. Heavner MS, Tichy E. Stepping it up: implementation of a pharmacist career ladder program. American Society of Health-System Pharmacists, December 2016. Las Vegas, NV.
  6. Littlefield A, Chan C, Cooper C, Heavner JJ, Kurtz J, Pisani M, Heavner MS. Correlation between mMINDS and CIWA-Ar scoring tools in patients with alcohol withdrawal syndrome. Society of Critical Care Medicine, January 2017. Honolulu, HI.
  7. Heavner MS. Developing, Implementing and Evaluating an ICU Specific Alcohol Withdrawal Protocol. New England Critical Care Pharmacotherapy Symposium, March 2017. Dedham, MA.
  8. Heavner MS. Pharmacokinetic & pharmacodynamic changes in critically ill patients. Maryland Critical Care Project, March 2017. Baltimore, MD.